Studies of cocrystal-excipient interaction by a combination of experimental and computational approaches.
Studies of cocrystal-excipient interaction by a combination of experimental and computational approaches.
Herein is presented a report on the study of a low-solubility active pharmaceutical ingredient (API), Leflunomide (LEF). Novel multi-component systems, both pharmaceutically and non-pharmaceutically acceptable, of LEF have been synthesised. Their multi-component nature was confirmed, and each system has been comprehensively characterised using X-ray Powder Diffraction (XRPD), Single-Crystal X-ray Diffraction (SCXRD) and detailed structural analysis.
A cocrystal design approach, using judicious selection of coformers based upon crystal-engineering principles was taken for the cocrystal screening process. This resulted in five new cocrystal systems, four of which are pharmaceutically acceptable. All pharmaceutically acceptable cocrystals were subjected to a comprehensive evaluation of their physicochemical properties, such as thermal properties, stability, dissolution rate and solubility. These were performed alongside that of LEF, in order to compare the physicochemical behaviour of the cocrystals with their parent API. This been performed using a variety of techniques, including DSC, TGA, DVS, XRPD, HPLC, and FTIR.
The two most promisingly performing cocrystals were then selected for further experimental formulation studies alongside complementary molecular dynamics simulations; providing a combined approach to probe the relationship between cocrystal-excipient interactions in water and the associated factors determining the dissolution properties of cocrystal formulations. These formulations, with the excipients lactose (LAC) or dibasic calcium phosphate (DCP), were experimentally evaluated for their dissolution rates and solubilities; properties which appeared to be influenced by their formulation. The parameters deduced from MD simulations, such as solvent accessible surface area (SASA), intermolecular hydrogen bonds among formulation ingredients and water, and interaction energy between the API (or cocrystal) and water were found to be essential indicators of cocrystal formulation dissolution performance.
In order to strengthen the understanding of the impact of intermolecular and interparticular interactions on their physicochemical behaviour, the cocrystals subjected to formulation studies were also analysed through quantum crystallographic studies. Their related intermolecular interaction energies provide experimental insight into the role cocrystallisation plays in influencing solid-state stability, and therefore physicochemical performance.
This was performed via theoretical computational calculations, using PIXEL and Crystal Explorer, of intermolecular interaction energies and their individual energetic contributions to relate these properties to structural assembly and physicochemical properties.
University of Southampton
Cadden, Joseph
86c93935-5d3e-4c0c-bd73-af51f60c9d1c
2023
Cadden, Joseph
86c93935-5d3e-4c0c-bd73-af51f60c9d1c
Coles, Simon
3116f58b-c30c-48cf-bdd5-397d1c1fecf8
Day, Graeme
e3be79ba-ad12-4461-b735-74d5c4355636
Cadden, Joseph
(2023)
Studies of cocrystal-excipient interaction by a combination of experimental and computational approaches.
University of Southampton, Doctoral Thesis, 138pp.
Record type:
Thesis
(Doctoral)
Abstract
Herein is presented a report on the study of a low-solubility active pharmaceutical ingredient (API), Leflunomide (LEF). Novel multi-component systems, both pharmaceutically and non-pharmaceutically acceptable, of LEF have been synthesised. Their multi-component nature was confirmed, and each system has been comprehensively characterised using X-ray Powder Diffraction (XRPD), Single-Crystal X-ray Diffraction (SCXRD) and detailed structural analysis.
A cocrystal design approach, using judicious selection of coformers based upon crystal-engineering principles was taken for the cocrystal screening process. This resulted in five new cocrystal systems, four of which are pharmaceutically acceptable. All pharmaceutically acceptable cocrystals were subjected to a comprehensive evaluation of their physicochemical properties, such as thermal properties, stability, dissolution rate and solubility. These were performed alongside that of LEF, in order to compare the physicochemical behaviour of the cocrystals with their parent API. This been performed using a variety of techniques, including DSC, TGA, DVS, XRPD, HPLC, and FTIR.
The two most promisingly performing cocrystals were then selected for further experimental formulation studies alongside complementary molecular dynamics simulations; providing a combined approach to probe the relationship between cocrystal-excipient interactions in water and the associated factors determining the dissolution properties of cocrystal formulations. These formulations, with the excipients lactose (LAC) or dibasic calcium phosphate (DCP), were experimentally evaluated for their dissolution rates and solubilities; properties which appeared to be influenced by their formulation. The parameters deduced from MD simulations, such as solvent accessible surface area (SASA), intermolecular hydrogen bonds among formulation ingredients and water, and interaction energy between the API (or cocrystal) and water were found to be essential indicators of cocrystal formulation dissolution performance.
In order to strengthen the understanding of the impact of intermolecular and interparticular interactions on their physicochemical behaviour, the cocrystals subjected to formulation studies were also analysed through quantum crystallographic studies. Their related intermolecular interaction energies provide experimental insight into the role cocrystallisation plays in influencing solid-state stability, and therefore physicochemical performance.
This was performed via theoretical computational calculations, using PIXEL and Crystal Explorer, of intermolecular interaction energies and their individual energetic contributions to relate these properties to structural assembly and physicochemical properties.
Text
Joseph_Cadden_Doctoral_ Thesis_PDFA
- Version of Record
Text
PTD_Thesis_Cadden-SIGNED
Restricted to Repository staff only
More information
Submitted date: July 2022
Published date: 2023
Identifiers
Local EPrints ID: 478502
URI: http://eprints.soton.ac.uk/id/eprint/478502
PURE UUID: b2c56ff3-2816-491f-8ab9-7033725d8092
Catalogue record
Date deposited: 04 Jul 2023 17:40
Last modified: 18 Mar 2024 02:50
Export record
Contributors
Author:
Joseph Cadden
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics